Adrenomedullin: A Blood Vessel Peptide That Dilates From Both Sides

Adrenomedullin dilates blood vessels through two independent mechanisms — direct smooth muscle relaxation AND endothelial nitric oxide release — making it an exceptionally potent vasodilator.

Minamino, N et al.·Clinical hemorheology and microcirculation·2000·Moderate EvidenceReview
RPEP-00605ReviewModerate Evidence2000RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Review
Evidence
Moderate Evidence
Sample
Not reported

What This Study Found

Adrenomedullin dilates blood vessels through dual mechanisms — direct smooth muscle relaxation and endothelial NO release — with autocrine/paracrine production by vascular endothelial and smooth muscle cells.

Key Numbers

How They Did This

Review of adrenomedullin vascular biology covering production, receptor expression, signaling mechanisms, and roles in cardiovascular diseases.

Why This Research Matters

Understanding AM's dual vasodilatory mechanism explains its exceptional potency and suggests it could be therapeutically valuable for conditions requiring blood vessel relaxation.

The Bigger Picture

The vasculature has its own peptide signaling system for self-regulation. AM's autocrine/paracrine function means blood vessels can control their own tone independently of central nervous system input.

What This Study Doesn't Tell Us

Brief review with limited clinical data. The relative importance of each vasodilatory mechanism may vary between vascular beds.

Questions This Raises

  • ?Could AM administration treat hypertension or heart failure?
  • ?Does AM's compensatory rise in heart failure help or hurt?
  • ?Can AM be delivered to specific vascular beds for targeted therapy?

Trust & Context

Key Stat:
Dual vasodilatory mechanism AM works through both direct smooth muscle relaxation AND endothelial NO release, explaining its exceptional blood pressure-lowering potency
Evidence Grade:
Moderate evidence from a focused review of vascular adrenomedullin biology.
Study Age:
Published in 2000. Adrenomedullin's vascular role is well established, with ADM-targeting therapies in development for sepsis and heart failure.
Original Title:
Adrenomedullin: a new peptidergic regulator of the vascular function.
Published In:
Clinical hemorheology and microcirculation, 23(2-4), 95-102 (2000)
Database ID:
RPEP-00605

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

Summarizes existing research on a topic.

What do these levels mean? →

Frequently Asked Questions

What makes adrenomedullin special as a vasodilator?

It works from both sides of the blood vessel wall — relaxing the muscle layer directly AND triggering the inner lining to release nitric oxide. This dual mechanism makes it one of the most potent blood pressure-lowering peptides.

Do blood vessels make their own blood pressure regulators?

Yes. Blood vessels produce adrenomedullin and have receptors for it, creating a self-regulatory system. This allows vessels to adjust their own tone locally, independent of hormones from distant organs.

Read More on RethinkPeptides

Cite This Study

RPEP-00605·https://rethinkpeptides.com/research/RPEP-00605

APA

Minamino, N; Kangawa, K; Matsuo, H. (2000). Adrenomedullin: a new peptidergic regulator of the vascular function.. Clinical hemorheology and microcirculation, 23(2-4), 95-102.

MLA

Minamino, N, et al. "Adrenomedullin: a new peptidergic regulator of the vascular function.." Clinical hemorheology and microcirculation, 2000.

RethinkPeptides

RethinkPeptides Research Database. "Adrenomedullin: a new peptidergic regulator of the vascular ..." RPEP-00605. Retrieved from https://rethinkpeptides.com/research/minamino-2000-adrenomedullin-a-new-peptidergic

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.